Is there a Bangladeshi generic version of Cabozantinib?

Cabozantinib (Cabozantinib), as a multi-target tyrosine kinase inhibitor, has shown significant therapeutic effects in clinical trials, especially in the treatment of some cancer types, and has achieved positive results.

Cabozantinib has a Bangladeshi generic version. Cabozantinib is not yet available in China and is not included in medical insurance, so it needs to be purchased through overseas channels. There are original drugs abroad, which cost around 35,000~46,000 yuan. Foreign generic drugs are mainly Lao generic drugs and Bangladeshi generic drugs, with prices ranging from 1,300 to 2,700 yuan. The price is much cheaper than original drugs and is more suitable for the needs of patients in ordinary families. The ingredients of original drugs and generic drugs are basically the same.

Cabozantinib is widely used in the first-line treatment of renal cell carcinoma. Clinical trials have shown that cabozantinib is superior to placebo in extending overall survival and progression-free survival. The study also showed greater pain relief and better tumor shrinkage in the cabozantinib group compared with placebo. Therefore, cabozantinib becomes a first-line treatment option for patients with advanced or metastatic renal cell carcinoma.

Cabozantinib is also used to treat certain patients with thyroid cancer, particularly those with locally advanced or metastatic disease that have not responded to radioactive iodine therapy. Clinical trials have shown that cabozantinib treatment can significantly extend the overall survival and progression-free survival of patients, and improve the effectiveness of treatment.

In the treatment of hepatocellular carcinoma, cabozantinib is often used as second-line treatment for patients who have relapsed or progressed after treatment with sorafenib (Sorafenib ). Clinical trials found that overall survival and disease control rates were significantly improved in the cabozantinib treatment group compared with placebo.